People

Donmienne Leung

Donmienne Leung is listed by EndLyz Therapeutics as Board Member; AbbVie Ventures Representative. Published current affiliation reviewed October8,2026; exact appointment day is not established. Donmienne Leung is published in AbbVie’s venture team as Director II, Head of AbbVie Ventures Europe. Drug-discovery scientist with preclinical small-molecule and biologics development experience.